NOAH
Clinical Trial Program
Neoadjuvant trastuzumab in patients with HER2-positive locally advanced breast cancer: a randomized phase III trial with a parallel HER2-negative cohort
Phase III
Status
Finished
Tumour subtype:
HER2+
Scenario
Neoadjuvant
SPONSOR
COLLABORATORS
PRINCIPAL INVESTIGATORS
José Baselga, MD, PhD (Hospital Universitari Vall d'Hebron, Barcelona)
Luca Gianni, MD (San Raffaele Cancer Center)
Sites
